These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2195108)

  • 21. [Beneficial effects of glucagon-insulin infusion on hepatic protein synthesis and DNA synthesis in partial hepatic ischemia].
    Kurihara M; Miyazaki M; Shimura T; Takahashi O; Okui K
    Nihon Geka Gakkai Zasshi; 1989 Jul; 90(7):1019-25. PubMed ID: 2677661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Portal venous "goodies" and fulminant viral hepatitis.
    Sherlock S
    N Engl J Med; 1976 Dec; 295(27):1535-6. PubMed ID: 995164
    [No Abstract]   [Full Text] [Related]  

  • 23. Zinc content in liver of experimental fulminant hepatic failure rat.
    Kawanishi H; Nishiki M; Tsuchiya T; Ezaki H
    Hiroshima J Med Sci; 1983 Sep; 32(3):305-9. PubMed ID: 6358141
    [No Abstract]   [Full Text] [Related]  

  • 24. A trial of glucagon in fulminant hepatitis.
    Narendranathan M; Nandini KK; Balakrishnan V
    J Assoc Physicians India; 1985 Mar; 33(3):219-20. PubMed ID: 4044480
    [No Abstract]   [Full Text] [Related]  

  • 25. Reciprocal changes in serum albumin and alpha-fetoprotein levels in the recovery course of acute viral hepatitis stimulated by glucagon and insulin therapy: analysis of a double blind controlled trial.
    Fujiwara K; Ogata I; Oka H
    Gastroenterol Jpn; 1989 Apr; 24(2):143-8. PubMed ID: 2472994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exercise-induced changes in insulin and glucagon are not required for enhanced hepatic glucose uptake after exercise but influence the fate of glucose within the liver.
    Pencek RR; James FD; Lacy DB; Jabbour K; Williams PE; Fueger PT; Wasserman DH
    Diabetes; 2004 Dec; 53(12):3041-7. PubMed ID: 15561932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary polyamine excretion measured by a simple enzymatic method is clinically useful as an expression of hepatic regeneration in liver diseases.
    Izumi N; Yauchi T; Enomoto N; Miyake S; Hasumura Y
    Hepatogastroenterology; 1990 Dec; 37 Suppl 2():107-9. PubMed ID: 2083920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superior efficacy of pulsatile versus continuous hormone exposure on hepatic glucose production in vitro.
    Komjati M; Bratusch-Marrain P; Waldhäusl W
    Endocrinology; 1986 Jan; 118(1):312-9. PubMed ID: 3000741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma.
    Klein D; Schubert T; Horch RE; Jauch KW; Jeschke MG
    Ann Surg; 2004 Aug; 240(2):340-9. PubMed ID: 15273560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Stimulation of hepatic regeneration].
    Oka H
    Nihon Naika Gakkai Zasshi; 1984 Jun; 73(6):785-8. PubMed ID: 6387011
    [No Abstract]   [Full Text] [Related]  

  • 31. [Changes in poly (ADP-ribose) polymerase activity in post-hepatectomized rat liver nuclei with glucagon and insulin].
    Fujii Y
    Nihon Geka Gakkai Zasshi; 1989 Mar; 90(3):385-95. PubMed ID: 2505048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letter: Synergistic action of insulin and glucagon in hepatic regeneration.
    Bucher NL; Swaffield MN
    Lancet; 1976 Mar; 1(7960):646. PubMed ID: 55929
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatic regeneration in the rat without portal organs.
    Whittemore AD; Kasuya M; Fodor PB; Price JB; Voorhees AB
    Surg Forum; 1973; 24():384-5. PubMed ID: 4806032
    [No Abstract]   [Full Text] [Related]  

  • 34. A multi-centre double-blind controlled trial of glucagon and insulin therapy for severe acute hepatitis.
    Oka H; Fujiwara K; Okita K; Ishii H; Sakuma A
    Gastroenterol Jpn; 1989 Jun; 24(3):332-6. PubMed ID: 2663609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial.
    Keays R; Harrison PM; Wendon JA; Forbes A; Gove C; Alexander GJ; Williams R
    BMJ; 1991 Oct; 303(6809):1026-9. PubMed ID: 1954453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin and glucagon infusion in acute alcoholic hepatitis: a prospective randomized controlled trial.
    Bird G; Lau JY; Koskinas J; Wicks C; Williams R
    Hepatology; 1991 Dec; 14(6):1097-101. PubMed ID: 1959860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral and hepatic resistance to insulin and hepatic resistance to glucagon in uraemic subjects. Studies at physiologic and supraphysiologic hormone levels.
    Schmitz O
    Acta Endocrinol (Copenh); 1988 May; 118(1):125-34. PubMed ID: 2898853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals.
    Matsuda M; Defronzo RA; Glass L; Consoli A; Giordano M; Bressler P; Delprato S
    Metabolism; 2002 Sep; 51(9):1111-9. PubMed ID: 12200754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Insulin and glucagon in the treatment of acute liver failure].
    Zielińska W; Jasiel M; Wojciechowicz G
    Pol Arch Med Wewn; 1981; 66(5-6):401-11. PubMed ID: 7043421
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of somatostatin on the hepatic extraction of insulin and glucagon in the anesthetized dog.
    Ishida T; Röjdmark S; Bloom G; Chou MC; Field JB
    Endocrinology; 1980 Jan; 106(1):220-30. PubMed ID: 7349954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.